Interleukin-36 Receptor Antagonist [EPC]

403 reported adverse events

Drugs of this class: SPESOLIMAB SPESOLIMAB-SBZO

These side effects are most commonly reported by patients taking drugs of the Interleukin-36 Receptor Antagonist [EPC] class:

# Side effect Count
0 GENERALISED PUSTULAR PSORIASIS 82
1 DRUG INEFFECTIVE 54
2 OFF LABEL USE 26
3 PRURITUS 22
4 RASH 20
5 FATIGUE 19
6 PUSTULAR PSORIASIS 19
7 PSORIASIS 16
8 PUSTULE 15
9 MATERNAL EXPOSURE DURING PREGNANCY 14
See all common reactions for Interleukin-36 Receptor Antagonist [EPC]

Drugs of the Interleukin-36 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENERALISED PUSTULAR PSORIASIS 82 0.2828
1 PARANEOPLASTIC DERMATOSIS 1 0.2000
2 KERION 1 0.0769
3 BENIGN FAMILIAL HAEMATURIA 1 0.0667
4 DERMATOLOGIC EXAMINATION ABNORMAL 1 0.0455
5 PSORIASIS AREA SEVERITY INDEX INCREASED 7 0.0424
6 PARATHYROID GLAND OPERATION 3 0.0200
7 LEIOMYOSARCOMA METASTATIC 1 0.0147
8 MEDICAL DEVICE SITE ABSCESS 1 0.0145
9 MYRINGITIS 1 0.0135
See all enriched reactions for Interleukin-36 Receptor Antagonist [EPC]